A detailed history of Shelton Capital Management transactions in United Therapeutics Corp stock. As of the latest transaction made, Shelton Capital Management holds 1,726 shares of UTHR stock, worth $622,861. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,726
Previous 1,726 -0.0%
Holding current value
$622,861
Previous $549,000 12.57%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$228.26 - $319.04 $68,021 - $95,073
-298 Reduced 14.72%
1,726 $549,000
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $47,703 - $57,040
-222 Reduced 9.88%
2,024 $445,000
Q2 2023

Aug 10, 2023

SELL
$205.19 - $232.99 $13,747 - $15,610
-67 Reduced 2.9%
2,246 $495,000
Q4 2022

Feb 13, 2023

SELL
$205.95 - $280.43 $13,592 - $18,508
-66 Reduced 2.77%
2,313 $643,000
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $15,482 - $18,150
-84 Reduced 3.41%
2,379 $514,000
Q1 2021

May 14, 2021

SELL
$153.94 - $174.85 $14,316 - $16,261
-93 Reduced 3.64%
2,463 $412,000
Q2 2020

Aug 12, 2020

SELL
$92.74 - $125.82 $19,846 - $26,925
-214 Reduced 7.73%
2,556 $309,000
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $185,966 - $295,380
2,445 Added 752.31%
2,770 $216,000
Q1 2019

May 10, 2019

SELL
$107.15 - $126.84 $261,981 - $310,123
-2,445 Reduced 88.27%
325 $2.77 Million
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $46,207 - $65,486
-431 Reduced 13.46%
2,770 $311,000
Q3 2017

Nov 28, 2017

BUY
$114.6 - $136.81 $366,834 - $437,928
3,201 New
3,201 $375,000
Q3 2017

Nov 14, 2017

SELL
$114.6 - $136.81 $366,834 - $437,928
-3,201 Closed
0 $0
Q1 2017

Nov 28, 2017

BUY
N/A
704 Added 28.19%
3,201 $433,000
Q4 2016

Nov 29, 2017

SELL
N/A
-2,054 Reduced 45.13%
2,497 $358,000
Q3 2016

Dec 06, 2017

BUY
N/A
2,054 Added 82.26%
4,551 $537,000
Q3 2016

Dec 04, 2017

BUY
N/A
2,497
2,497 $358,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.